Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Equity Ratio (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Equity Ratio over the past 15 years, most recently at 0.01 for Q2 2025.

  • For Q2 2025, Equity Ratio fell 87.47% year-over-year to 0.01; the TTM value through May 2025 reached 0.01, down 87.47%, while the annual FY2025 figure was 0.01, 87.47% down from the prior year.
  • Equity Ratio for Q2 2025 was 0.01 at Lifecore Biomedical, Inc. \De\, down from 0.01 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.44 in Q1 2022 and troughed at 0.06 in Q3 2023.
  • A 5-year average of 0.18 and a median of 0.11 in 2023 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: crashed 118.88% in 2023 and later skyrocketed 946.45% in 2024.
  • Year by year, Equity Ratio stood at 0.37 in 2021, then plummeted by 30.12% to 0.26 in 2022, then crashed by 97.76% to 0.01 in 2023, then skyrocketed by 946.45% to 0.06 in 2024, then crashed by 90.77% to 0.01 in 2025.
  • Business Quant data shows Equity Ratio for LFCR at 0.01 in Q2 2025, 0.01 in Q1 2025, and 0.06 in Q4 2024.